Your browser doesn't support javascript.
loading
Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine.
Knutson, Keith L; Block, Matthew S; Norton, Nadine; Erskine, Courtney L; Hobday, Timothy J; Dietz, Allan B; Padley, Douglas; Gustafson, Michael P; Puglisi-Knutson, Danell; Mangskau, Toni Kay; Chumsri, Saranya; Dueck, Amylou C; Karyampudi, Lavakumar; Wilson, Glynn; Degnim, Amy C.
Afiliação
  • Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, Florida. knutson.keith@mayo.edu degnim.amy@mayo.edu.
  • Block MS; Department of Oncology, Mayo Clinic, Rochester, Minnesota.
  • Norton N; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida.
  • Erskine CL; Department of Immunology, Mayo Clinic, Rochester, Minnesota.
  • Hobday TJ; Department of Oncology, Mayo Clinic, Rochester, Minnesota.
  • Dietz AB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Padley D; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Gustafson MP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Puglisi-Knutson D; Department of Immunology, Mayo Clinic, Rochester, Minnesota.
  • Mangskau TK; Mayo Clinic Cancer Education Program, Mayo Clinic, Rochester, Minnesota.
  • Chumsri S; Department of Oncology, Mayo Clinic, Jacksonville, Florida.
  • Dueck AC; Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona.
  • Karyampudi L; Department of Immunology, Mayo Clinic, Rochester, Minnesota.
  • Wilson G; Marker Therapeutics, Inc., Houston, Texas.
  • Degnim AC; Department of Surgery, Mayo Clinic, Rochester, Minnesota. knutson.keith@mayo.edu degnim.amy@mayo.edu.
Clin Cancer Res ; 26(5): 1045-1053, 2020 03 01.
Article em En | MEDLINE | ID: mdl-31757875
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Neoplasias da Mama / Linfócitos T / Antígenos de Histocompatibilidade Classe II / Receptor ErbB-2 / Vacinas Anticâncer / Epitopos Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Neoplasias da Mama / Linfócitos T / Antígenos de Histocompatibilidade Classe II / Receptor ErbB-2 / Vacinas Anticâncer / Epitopos Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article